
- Mount Sinai Doctors
- Accepting New Patients
Robert M Samstein, MD, PhD
Radiation Oncology
About Me
Robert (Robbie) Samstein, MD PhD is a radiation oncologist in the Department of Radiation Oncology at Mount Sinai and a physician scientist with a laboratory in the Precision Immunology Institute at Mount Sinai. He treats a wide variety of cancer, specializing in thoracic malignancies. He graduated summa cum laude from Yale University and completed his combined MD-PhD training in the Tri-Institutional Weill Cornell/ Memorial Sloan Kettering/ Rockefeller MD-PhD Program. He completed his graduate work with Alexander Rudensky studying the development and function of regulatory T cells. He completed his transitional year internship and residency in radiation oncology at Memorial Sloan Kettering Cancer Center in New York, NY. During residency, he conducted laboratory research with Dr. Timothy Chan as part of the American Board of Radiology Holman Research pathway.
Dr. Samstein’s research interests are focused on understanding the interaction between the patient’s immune system and cancer cells in the tumor, elucidating the role of the DNA damage repair and response pathway in altering the tumor’s ability to be recognized and attacked by the immune system. His laboratory will work to identify new strategies to harness the immune anti-tumor response and expand the therapeutic window of traditional immunotherapies.
Language
English
Position
ASSOCIATE PROFESSOR | Radiation Oncology, ASSOCIATE PROFESSOR | Immunology & Immunotherapy
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Research Topics
Anti-Tumor Therapy, Autoimmunity, Biomedical Sciences, Breast Cancer, Cancer, Cancer Genetics, Cellular Immunity, Clinical Genomics, DNA Recombination, DNA Repair, Genetics, Genomics, Immunology, Mucosal Immunology, Oncogenes, Personalized Medicine, Pharmacogenomics, T Cells, Translational Research, Tumor Suppressor Genes, Tumorigenesis
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Immunology [IMM]
Clinical Focus
- Bone Metastasis Treatment
- Brain Tumor And Brain Cancer
- Breast Cancer
- Cancer Treatment
- Lung Cancer
- Melanoma
- Mesothelioma
- Pancreatic Cancer
- Radiation Oncology Second Opinion
- Radiation Therapy
- Skin Cancer
- Stereotactic Radiosurgery
- Thymoma
Education
MD, Weill Medical College of Cornell University
MD, Weill Cornell Medical College
PhD, Weill Cornell / Sloan Kettering / Rockefeller Tri-I MD-PhD Program
, Memorial Sloan Kettering Cancer Center
Internship, Transitional Year
Memorial Sloan-Kettering Cancer Center
Residency, Radiation Oncology
Memorial Sloan-Kettering Cancer Center
Certifications
Radiation Oncology
Awards
2020
Solomon Silver Award in Clinical Medicine
2020
American Association of Immunologists Pfizer-Showell Award
2019
Burrough Wellcome Career Award for Medical Scientists
2019
RSNA Roentgen Reseach Award
2018
AACR Translational Immunology Award
2017
American Board of Radiology Holman Research Pathway
Research
Visit the Samstein Laboratory
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information. Patients with Anthem Blue Cross Blue Shield (formerly known as Empire) or Molina insurance: please visit the linked pages in this message before booking to find out if out-of-network costs may apply to your next visit.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers. Roman M. Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki, Marine Aglave, Jean Zeghondy, Victor Kriaa, Antoine Gougé, Marlène Garrido, Elodie Edmond, Ludovic Bigot, Dragomir B. Krastev, Rachel Brough, Stephen J. Pettitt, Thibault Thomas-Bonafos, Robert Samstein, Christophe Massard, Marc Deloger, Andrew N.J. Tutt, Fabrice Barlesi, Yohann Loriot, Suzette Delaloge, Marcel Tawk, Cindy Degerny, Yea Lih Lin, Barbara Pistilli, Philippe Pasero, Christopher J. Lord, Sophie Postel-Vinay. Nature Communications
- Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC. Celine Mascaux, Triparna Sen, Montse Sanchez-Cespedes, Sandra Ortiz-Cuaran, Yohan Bossé, Floris Dammeijer, Milena Cavic, Martin P. Barr, Surein Arulananda, Ricardo Armisen, Alice H. Berger, Fabrizio Bianchi, David P. Carbone, Ferdinando Cerciello, William W. Lockwood, Tetsuya Mitsudomi, Shuta Ohara, Katerina Politi, Sida Qin, Laila C. Roisman, Robert Samstein, Ferdinandos Skoulidis, Aaron C. Tan, Anish Thomas, Jianjun Zhang, Murry W. Wynes, Thomas John, Ming Sound Tsao. Journal of Thoracic Oncology
- PlanAct: An eclipse scripting API-based module embedding clinical optimization strategies for automated planning in locally advanced non-small cell lung cancer. Hao Guo, Tenzin Kunkyab, Yang Lei, Kenneth Rosenzweig, Robert Samstein, Ming Chao, Tian Liu, Junyi Xia, Jiahan Zhang. Journal of Applied Clinical Medical Physics
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Samstein during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- International Association for the Study of Lung Cancer
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.